July 29, 2019 | Letisia Marquez
City of Hope has been named the best cancer hospital in the West by U.S. News & World Report’s 2019-20 Best Hospitals: Specialty Ranking. This marks the 13th consecutive year it has been distinguished as one of the nation’s elite cancer hospitals.
Innovative approach using KITE-439 in targeting HPV-related malignancies
August 20, 2019 | City of Hope
HPV16-induced cancers, a strain that causes about 70% of all cervical cancers worldwide, are ideal candidates for targeted T cell therapy due to their nonself antigens.
City of Hope scientist receives $9.28M for CAR T trial for metastatic breast cancer
August 15, 2019 | Letisia Marquez
Saul Priceman, Ph.D., and his research team have received a $9.28 million award from the California Institute for Regenerative Medicine to support a CAR T cell phase 1 clinical trial for the treatment of women with HER2-positive breast cancer that has spread to the brain.
Vanessa Jonsson, Ph.D.: An engineer tackles CAR T cell therapy
February 13, 2019 | City of Hope
Vanessa Jonsson, Ph.D., focuses on chimeric antigen receptor (CAR) T cell therapy. Using such tools as computational analysis and mathematical modeling, she examines the complex interactions between the tumor, the patient’s immune system and the therapy to learn how the tumor evades the immune response.
Evolution of Treatment Resistance in Metastatic Breast Cancer Tracked in New Study
November 9, 2017 | City of Hope
Findings from a new study provide fresh insights into the treatment of women with metastatic breast cancer whose tumors are no longer responding to available treatments.
Stage 4 Metastatic Breast Cancer: In Remission and Loving Life
October 7, 2016 | Samantha Bonar
Daryn Rodriguez thought she was in the clear after aggressively treating her Stage 0 breast cancer with a double mastectomy. Eight years later the cancer returned and spread to her left femur. But that hasn't stopped her from living her life to the fullest.